{
  "docId": "019dd923-5fed-74f2-a971-0525f53d820a",
  "docSlug": "bi-2948c5096d6afcc9",
  "documentTitle": "Pitch deck: 64x Bio raises $55 million for cell, gene therapy tools.",
  "authorId": "Pitchdecks",
  "authorName": "64x Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.78,
  "pageNumber": 5,
  "pageCount": 10,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses authority-citation (news articles) to validate the problem statement.",
  "elementsJson": [
    "headline_text",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a971-0525f53d820a/5",
  "deckHref": "/decks/019dd923-5fed-74f2-a971-0525f53d820a",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a971-0525f53d820a.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a971-0525f53d820a#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "limiting new drug development",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-b119-70d4-8fd8-1a2a6fec4eaf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.4,
        "y": 0.46
      },
      "kind": "image",
      "text": "Pharmaceutical Technology article screenshot",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63314c01-4f90-4ae6-bdbf-939d953e937c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.16,
        "y": 0.48
      },
      "kind": "image",
      "text": "GEN article screenshot",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73e4517a-d3ee-43ff-957f-cdf1aa50ea94",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.6,
        "y": 0.2
      },
      "kind": "image",
      "text": "Fierce Pharma article screenshot",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c17e7098-a712-40d2-94d6-6967e6020182",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.06,
        "y": 0.3
      },
      "kind": "title",
      "text": "limiting new drug development",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67b414ee-1804-462c-9a7c-22d9f15d6944",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.06,
        "y": 0.14
      },
      "kind": "title",
      "text": "Viral vector manufacturing is a massive bottleneck",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6123026d-31af-4ee3-912f-f0e63827b587",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "2c8cded7-4f5a-4184-85ba-40095705f464",
      "evidence": "Uses industry news headlines to validate the problem statement.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "5ffa5aee-4346-4382-abb2-157577358310",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 4-6 present the problem and its consequences",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d905a159-6fb0-4083-8afd-332025b19084",
      "evidence": "The deck presents the consequences of the bottleneck",
      "position": 0,
      "objective": "What are the consequences of not solving the bottleneck?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}